Kite and Gilead UK&I 2024 CAR-T Fellowship and Medical Grants Programme now open

Kite and Gilead UK & Ireland CAR-T Fellowship and Medical Grants Programme

The Kite and Gilead UK and Ireland Fellowship and Medical Grants Programme (GFP) is a medical grants funding stream that supports innovative best practice projects and initiatives that aim to improve the lives of patients.

The 2024 CAR-T Fellowship and Medical Grants Programme is now open and will be accepting applications until 28th June. Applications are invited from healthcare and third sector organisations (e.g., charities) who are seeking funding for a project that aligns with the goals of the programme. The Programme is looking to support projects and initiatives (up to £50,000) which ultimately lead to an improvement in patient care. This can include, but is not limited to, activities such as:

  • Initiatives to facilitate improved efficiency in patient care and shared care pathways between referring and CAR-T treatment centres
  • Audits assessing patient profiles, disease outcomes and treatment patterns
  • Monitoring of patient-reported outcomes, quality of life measures or educational tools for patients and carers
  • New infrastructure/processes established for better diagnosis or detection of disease, or prediction or monitoring of safety and efficacy outcomes to treatment
  • Investigations into better detection and treatment of special patient populations and sub-types

Further information on the 2024 CAR-T Fellowship and Medical Grants Programme can be found on Gilead’s website.

Date of preparation: May 2024

Code: UK-UNB-5542.

 

Latest News

By BOPA Exec Committee on 15th September 2025

Invitation to visit the BOPA stand at the BOPA Conference in Belfast

Hello All As an Executive Committee we are looking forward to meeting those of you who are signed up to come to the conference in Belfast next month. The BOPA…

Read article
By BOPA Research subcommittee on 14th September 2025

Survey: Fertility and the use of Immune Checkpoint Inhibitor Therapy (Survey from Royal Marsden Hospital)

Immune checkpoint inhibitors, such as atezolizumab, nivolumab and pembrolizumab have transformed the treatment landscape for many cancers. Cancers such as melanoma and Lynch-syndrome related tumours necessitating immune checkpoint inhibitors are…

Read article
By Clayton Wong on 8th September 2025

British Oncology Pharmacy Association (BOPA) invites you to Clinical Pharmacy Congress North 2025

British Oncology Pharmacy Association (BOPA) invites you to Clinical Pharmacy Congress North 21-22 November 2025 | Manchester Central Confirm your free delegate place *free places are only available for registered healthcare…

Read article
By Clayton Wong on 8th September 2025

Opening soon: Abstract submission for the ISOPP International Symposium 2026  

Are you working on an innovative oncology pharmacy project, service evaluation, or research study? Here’s your chance to share it with a global audience! Submit your abstract(s) online by Friday,…

Read article